AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33347643 — intervention group
Group type: COMPARATOR
Intervention: Standard self-consistent field (SCF) approach accelerated by direct inversion of the iterative subspace (DIIS)
Number of subjects: 0
Study 35017127 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS targeting left dorsolateral prefrontal cortex (DLPFC)
Number of subjects: 64
Study 35017127 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS targeting lateral temporoparietal area (LTA)
Number of subjects: 64
Study 35017127 — intervention group
Group type: EXPERIMENTAL
Intervention: Active DLPFC-tDCS
Number of subjects: 64
Study 35017127 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 64
Study 35017127 — intervention group
Group type: COMPARATOR
Intervention: Rest (no stimulation)
Number of subjects: 64
Study 34741843 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral episiotomy
Number of subjects: 19
Study 34741843 — intervention group
Group type: COMPARATOR
Intervention: No episiotomy
Number of subjects: 19
Study 32867777 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug abuse
Number of subjects: 2000
Study 32867777 — intervention group
Group type: EXPERIMENTAL
Intervention: Hookah
Number of subjects: 2000
Study 32867777 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol drinking
Number of subjects: 2000
Study 32867777 — intervention group
Group type: EXPERIMENTAL
Intervention: Tobacco smoking
Number of subjects: 2000
Study 32867777 — intervention group
Group type: EXPERIMENTAL
Intervention: Extramarital intercourse
Number of subjects: 2000
Study 32867777 — intervention group
Group type: EXPERIMENTAL
Intervention: Gambling
Number of subjects: 2000
Study 34913020 — intervention group
Group type: EXPERIMENTAL
Intervention: Ergocalciferol (50,000 IU per week for 2 months, then once every 2 weeks for 10 months)
Number of subjects: 36
Study 34913020 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 35260317 — intervention group
Group type: EXPERIMENTAL
Intervention: Full ban on ENDS in Massachusetts
Number of subjects: 3
Study 35260317 — intervention group
Group type: EXPERIMENTAL
Intervention: Banning non-tobacco flavored ENDS
Number of subjects: 3
Study 35260317 — intervention group
Group type: COMPARATOR
Intervention: Halted states (revoked ENDS bans)
Number of subjects: 3
Study 35260317 — intervention group
Group type: COMPARATOR
Intervention: Control states (placebo tests)
Number of subjects: 3
Study 34228505 — intervention group
Group type: EXPERIMENTAL
Intervention: Calaspargase (2,500 IU/m2/dose, every 3 weeks for 10 doses)
Number of subjects: 239
Study 34228505 — intervention group
Group type: COMPARATOR
Intervention: Pegaspargase (2,500 IU/m2/dose, every 2 weeks for 15 doses)
Number of subjects: 239
Study 34228505 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 239
Study 33087221 — intervention group
Group type: EXPERIMENTAL
Intervention: Composite strip crowns (CSCs)
Number of subjects: 49
Study 33087221 — intervention group
Group type: COMPARATOR
Intervention: NuSmile preveneered stainless steel crowns (PVSSCs)
Number of subjects: 49
Study 33087221 — intervention group
Group type: COMPARATOR
Intervention: NuSmile zirconia crowns (ZCs)
Number of subjects: 49
Study 35841057 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of nanofat subcutaneously and SVF intradermally
Number of subjects: 7
Study 35841057 — intervention group
Group type: COMPARATOR
Intervention: Nanofat subcutaneously (control group)
Number of subjects: 7
Study 32302702 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab + Carboplatin + Nab-Paclitaxel (A+CnP)
Number of subjects: 1021
Study 32302702 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin + Nab-Paclitaxel (CnP)
Number of subjects: 1021
Study 36104781 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured physiotherapy with workplace dialogue
Number of subjects: 352
Study 36104781 — intervention group
Group type: COMPARATOR
Intervention: Structured physiotherapy alone
Number of subjects: 352
Study 34112627 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP)
Number of subjects: 33
Study 34112627 — intervention group
Group type: COMPARATOR
Intervention: Control (no MOP)
Number of subjects: 33
Study 32362231 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control
Number of subjects: 9327
Study 32362231 — intervention group
Group type: COMPARATOR
Intervention: Standard blood pressure control
Number of subjects: 9327
Study 32362231 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexisting AF
Number of subjects: 9327
Study 32362231 — intervention group
Group type: EXPERIMENTAL
Intervention: New-onset AF
Number of subjects: 9327
Study 32362231 — intervention group
Group type: EXPERIMENTAL
Intervention: Preexisting AF with BP <120/80 mm Hg at 3 months
Number of subjects: 9327
Study 32779544 — intervention group
Group type: EXPERIMENTAL
Intervention: MIP60 (60% maximal inspiratory pressure, 3×10 repetitions)
Number of subjects: 21
Study 32779544 — intervention group
Group type: EXPERIMENTAL
Intervention: MIP30 (30% maximal inspiratory pressure, 3×20 repetitions)
Number of subjects: 21
Study 32401418 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed electromagnetic field (PEMF) therapy
Number of subjects: 30
Study 32401418 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30
Study 32703623 — intervention group
Group type: EXPERIMENTAL
Intervention: ReDS-guided therapy
Number of subjects: 108
Study 32703623 — intervention group
Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 108
Study 33175970 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 PUFAs
Number of subjects: 0
Study 33175970 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 36262374 — intervention group
Group type: EXPERIMENTAL
Intervention: PEMF therapy (1 mT for 10 min weekly for 16 weeks)
Number of subjects: 20
Study 36262374 — intervention group
Group type: COMPARATOR
Intervention: Sham exposure (control)
Number of subjects: 20
Study 34878212 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual results from the study
Number of subjects: 16
Study 34878212 — intervention group
Group type: EXPERIMENTAL
Intervention: Summary of overall trial results
Number of subjects: 16
Study 34878212 — intervention group
Group type: EXPERIMENTAL
Intervention: A thank you for your contribution to the study
Number of subjects: 16
Study 34878212 — intervention group
Group type: EXPERIMENTAL
Intervention: Delivery by post
Number of subjects: 16
Study 34878212 — intervention group
Group type: EXPERIMENTAL
Intervention: Hard copy of results
Number of subjects: 16
Study 32866761 — intervention group
Group type: COMPARATOR
Intervention: Brivaracetam
Number of subjects: 12739
Study 32866761 — intervention group
Group type: COMPARATOR
Intervention: Pregabalin
Number of subjects: 12739
Study 32866761 — intervention group
Group type: COMPARATOR
Intervention: Levetiracetam
Number of subjects: 12739
Study 32866761 — intervention group
Group type: COMPARATOR
Intervention: Carisbamate
Number of subjects: 12739
Study 32866761 — intervention group
Group type: COMPARATOR
Intervention: 9 AEDs
Number of subjects: 12739
Study 34488858 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous IVM at 200 ?g/kg/48 h (Arm A)
Number of subjects: 180
Study 34488858 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous IVM at 200 ?g/kg/48 h and oral Zn 20mg/8 h (Arm B)
Number of subjects: 180
Study 34488858 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral IVM at 0.2 mg/kg/day (Arm C)
Number of subjects: 180
Study 34488858 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral IVM at 0.2 mg/kg/day and oral Zn 20mg/8 h (Arm D)
Number of subjects: 180
Study 34488858 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral Zn 20mg/8 h (Arm E)
Number of subjects: 180
Study 34488858 — intervention group
Group type: COMPARATOR
Intervention: Placebo alone (Arm X)
Number of subjects: 180
Study 33538345 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating blue (470 nm) and red (640 nm) light in two visits per week for 4 consecutive weeks
Number of subjects: 30
Study 33538345 — intervention group
Group type: COMPARATOR
Intervention: Blue and red light treatments consecutively on the same visit for 4 consecutive weeks
Number of subjects: 30
Study 33232629 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT 135 J
Number of subjects: 18
Study 33232629 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT 270 J
Number of subjects: 18
Study 33232629 — intervention group
Group type: EXPERIMENTAL
Intervention: PBMT 540 J
Number of subjects: 18
Study 33232629 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 33232629 — intervention group
Group type: COMPARATOR
Intervention: Control (no PBMT)
Number of subjects: 18
Study 35639865 — intervention group
Group type: COMPARATOR
Intervention: Exercise alone
Number of subjects: 269
Study 35639865 — intervention group
Group type: COMPARATOR
Intervention: Diet alone
Number of subjects: 269
Study 35639865 — intervention group
Group type: COMPARATOR
Intervention: Exercise plus diet
Number of subjects: 269
Study 33662124 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone (12-day postoperative taper)
Number of subjects: 72
Study 33662124 — intervention group
Group type: COMPARATOR
Intervention: Matched placebo tablets
Number of subjects: 72
Study 32879954 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluid Restriction (FR) 1 liter/day
Number of subjects: 46
Study 32879954 — intervention group
Group type: COMPARATOR
Intervention: No treatment (NoTx)
Number of subjects: 46
Study 35788727 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness yoga + conventional care
Number of subjects: 136
Study 35788727 — intervention group
Group type: COMPARATOR
Intervention: Conventional care
Number of subjects: 136
Study 34494889 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate SSC (at birth)
Number of subjects: 297
Study 34494889 — intervention group
Group type: COMPARATOR
Intervention: Early SSC (at 60 minutes of life)
Number of subjects: 297
Study 34987795 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal and oropharyngeal rinses with neutral electrolyzed water (SES), three times a day for 4 weeks
Number of subjects: 170
Study 34987795 — intervention group
Group type: COMPARATOR
Intervention: Control group (no SES rinses)
Number of subjects: 170
Study 35148396 — intervention group
Group type: EXPERIMENTAL
Intervention: Evening sleep schedule (15:00-23:00)
Number of subjects: 60
Study 35148396 — intervention group
Group type: COMPARATOR
Intervention: Morning sleep schedule (09:00-17:00)
Number of subjects: 60
Study 33705727 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 µg with Algel-IMDG
Number of subjects: 380
Study 33705727 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 µg with Algel-IMDG
Number of subjects: 380
Study 33705727 — intervention group
Group type: COMPARATOR
Intervention: 6 µg with Algel
Number of subjects: 380
Study 33705727 — intervention group
Group type: COMPARATOR
Intervention: Algel alone
Number of subjects: 380
Study 32481440 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 40 mg/day
Number of subjects: 18
Study 32481440 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 35365197 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole and FSH
Number of subjects: 900
Study 35365197 — intervention group
Group type: COMPARATOR
Intervention: FSH alone
Number of subjects: 900
Study 34404147 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual training group
Number of subjects: 30
Study 36151554 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Nurse Partnership (FNP) plus usual care
Number of subjects: 476
Study 36151554 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 476
Study 32840871 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based intervention in physical education (PE) designed to train self-control
Number of subjects: 116
Study 32840871 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 116
Study 36349973 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary food and anti-infective treatments
Number of subjects: 1421
Study 34061145 — intervention group
Group type: EXPERIMENTAL
Intervention: Insertable cardiac monitor (ICM) within 10 days of the index stroke; n=242
Number of subjects: 496
Study 34061145 — intervention group
Group type: COMPARATOR
Intervention: Usual care consisting of external cardiac monitoring; n=250
Number of subjects: 496
Study 32843659 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-hour training regime with haptic sound-localisation
Number of subjects: 32
Study 32843659 — intervention group
Group type: COMPARATOR
Intervention: No training (control group)
Number of subjects: 32
Study 35602030 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistant maltodextrin (RMD)
Number of subjects: 29
Study 33870923 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma
Number of subjects: 74
Study 33870923 — intervention group
Group type: COMPARATOR
Intervention: Standard plasma
Number of subjects: 74
Study 34881370 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal live attenuated influenza vaccine (LAIV) administered at enrolment (day 0)
Number of subjects: 330
Study 34881370 — intervention group
Group type: COMPARATOR
Intervention: Control group (LAIV administered at the end of active follow-up, day 21)
Number of subjects: 330
Study 32886192 — intervention group
Group type: EXPERIMENTAL
Intervention: BetaMe/Melon digital health programme (12 months duration)
Number of subjects: 429
Study 32886192 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 429
Study 36428011 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA‐assisted psychotherapy (MDMA‐AP)
Number of subjects: 94
Study 36428011 — intervention group
Group type: COMPARATOR
Intervention: Control pharmacotherapy trial
Number of subjects: 94
Study 36428011 — intervention group
Group type: EXPERIMENTAL
Intervention: MDMA‐AP
Number of subjects: 94
Study 32370202 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised functional exercise and exercise counseling (1st phase) followed by home-based exercise on non-dialysis days (2nd phase) for 8 weeks each
Number of subjects: 40
Study 32370202 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised functional exercise
Number of subjects: 40
Study 32370202 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise
Number of subjects: 40
Study 32370202 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline DB score
Number of subjects: 40
Study 32370202 — intervention group
Group type: EXPERIMENTAL
Intervention: Low OEE and low DB scores
Number of subjects: 40
Study 35876941 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg caffeine
Number of subjects: 19
Study 35876941 — intervention group
Group type: COMPARATOR
Intervention: 30 g glucose
Number of subjects: 19
Study 35876941 — intervention group
Group type: COMPARATOR
Intervention: 300 ml water
Number of subjects: 19
Study 33284114 — intervention group
Group type: EXPERIMENTAL
Intervention: Two doses of intradermal f-IPV (administered at 14 and 36 weeks)
Number of subjects: 773
Study 33284114 — intervention group
Group type: COMPARATOR
Intervention: Two doses of intramuscular IPV (administered at 14 and 36 weeks)
Number of subjects: 773
Study 33284114 — intervention group
Group type: EXPERIMENTAL
Intervention: Three doses of intradermal f-IPV (administered at 10, 14, and 36 weeks)
Number of subjects: 773
Study 33284114 — intervention group
Group type: COMPARATOR
Intervention: Three doses of intramuscular IPV (administered at 10, 14, and 36 weeks)
Number of subjects: 773
Study 33884980 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal midazolam 0.2 mg/kg
Number of subjects: 100
Study 33884980 — intervention group
Group type: COMPARATOR
Intervention: Intranasal dexmedetomidine 2 μg/kg
Number of subjects: 100
Study 33551199 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit program with telephone communication every two weeks for two months, then once during months four and five.
Number of subjects: 46
Study 33551199 — intervention group
Group type: COMPARATOR
Intervention: Fitbit program with electronic communication (email/text).
Number of subjects: 46
Study 33551199 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit program (both interventions).
Number of subjects: 46
Study 32022371 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg oral temazepam
Number of subjects: 0
Study 33202337 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 0
Study 33202337 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 0
Study 33202337 — intervention group
Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 0
Study 33202337 — intervention group
Group type: COMPARATOR
Intervention: Olanzapine
Number of subjects: 0
Study 32588515 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.2 mg/day for 6 months plus celecoxib 200 mg/day for 3 months
Number of subjects: 310
Study 32588515 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.2 mg/day for 6 months
Number of subjects: 310
Study 34953184 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.20% chlorhexidine with hyaluronic acid mouthwash
Number of subjects: 46
Study 34953184 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% chlorhexidine mouthwash
Number of subjects: 46
Study 34953184 — intervention group
Group type: COMPARATOR
Intervention: Basic periodontal therapy only
Number of subjects: 46
Study 33292916 — intervention group
Group type: EXPERIMENTAL
Intervention: Videoconference administration of neuropsychological measures
Number of subjects: 48
Study 33292916 — intervention group
Group type: COMPARATOR
Intervention: In-person administration of neuropsychological measures
Number of subjects: 48
Study 33023497 — intervention group
Group type: EXPERIMENTAL
Intervention: Interprofessional medication assessment
Number of subjects: 512
Study 33023497 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 512
Study 35351204 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education program promoting fruit and vegetable consumption
Number of subjects: 74
Study 35351204 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 74
Study 35247974 — intervention group
Group type: EXPERIMENTAL
Intervention: Bifidobacterium infantis CURE21, 1010 colony forming units/day for six weeks
Number of subjects: 14
Study 35247974 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactiplantibacillus plantarum 299 (Lp299), 1010 colony forming units/day for six weeks
Number of subjects: 14
Study 35247974 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 14
Study 32998108 — intervention group
Group type: EXPERIMENTAL
Intervention: ImKR (velocity feedback immediately after each repetition)
Number of subjects: 15
Study 32998108 — intervention group
Group type: EXPERIMENTAL
Intervention: HalfKR (velocity feedback after the first half of repetitions of each set)
Number of subjects: 15
Study 32998108 — intervention group
Group type: EXPERIMENTAL
Intervention: AvgKR (feedback of the average velocity of each set)
Number of subjects: 15
Study 32998108 — intervention group
Group type: COMPARATOR
Intervention: Control (no feedback)
Number of subjects: 15
Study 36471186 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent exercise training (CT)
Number of subjects: 59
Study 36471186 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 59
Study 34391410 — intervention group
Group type: EXPERIMENTAL
Intervention: Airflow with calcium carbonate
Number of subjects: 30
Study 34391410 — intervention group
Group type: EXPERIMENTAL
Intervention: Airflow with sodium bicarbonate
Number of subjects: 30
Study 34391410 — intervention group
Group type: COMPARATOR
Intervention: FlexiDisc (conventional polishing)
Number of subjects: 30
Study 32496902 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal Methotrexate (IT MTX)
Number of subjects: 0
Study 32496902 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal Triple Therapy (ITT)
Number of subjects: 0
Study 36457362 — intervention group
Group type: EXPERIMENTAL
Intervention: Group intervention (6-week intervention designed to improve psychosocial outcomes)
Number of subjects: 0
Study 36457362 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual intervention (6-week intervention via video)
Number of subjects: 0
Study 36457362 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 0
Study 33446472 — intervention group
Group type: EXPERIMENTAL
Intervention: Pingchan Granule (PCG)
Number of subjects: 85
Study 33446472 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 85
Study 32413350 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured reports
Number of subjects: 5155
Study 32413350 — intervention group
Group type: COMPARATOR
Intervention: Freestyle reports
Number of subjects: 5155
Study 32413350 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured reports indicating 'no acute disease'
Number of subjects: 5155
Study 32413350 — intervention group
Group type: EXPERIMENTAL
Intervention: 'No acute disease' impression
Number of subjects: 5155
Study 32413350 — intervention group
Group type: EXPERIMENTAL
Intervention: 'Negative chest' impression
Number of subjects: 5155
Study 35417778 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 polyunsaturated fatty acids (PUFA) supplementation for 4 weeks
Number of subjects: 42
Study 35417778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 34159199 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance training exercise (group 1)
Number of subjects: 60
Study 34159199 — intervention group
Group type: COMPARATOR
Intervention: Control group (group 2)
Number of subjects: 60
Study 35499363 — intervention group
Group type: EXPERIMENTAL
Intervention: Active hearing aids
Number of subjects: 37
Study 35499363 — intervention group
Group type: COMPARATOR
Intervention: Sham hearing aids
Number of subjects: 37
Study 34789000 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive atraumatic restorative treatment and the Hall technique approaches (ART-HT)
Number of subjects: 29
Study 34789000 — intervention group
Group type: COMPARATOR
Intervention: Delayed intervention group advised to seek dental care from their usual service provider
Number of subjects: 29
Study 35583870 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC
Number of subjects: 271
Study 35583870 — intervention group
Group type: EXPERIMENTAL
Intervention: ROC+
Number of subjects: 271
Study 35583870 — intervention group
Group type: EXPERIMENTAL
Intervention: BWL
Number of subjects: 271